Transdermal formulation, also known as transdermal drug delivery systems (TDDS) or transdermal therapeutic systems (TTS), refers to drug absorption through the skin into the human blood circulation, reaching an effective blood concentration to achieve disease prevention or treatment. With in-depth scientific research, transdermal formulation, considered the third largest drug delivery system after oral administration and injection, has become a convenient alternative to oral drugs and subcutaneous injections. It is also a popular area of pharmaceutical research and development. CD Formulation has been focusing on transdermal formulation for many years, and our experienced team can guide you in selecting and developing critical quality attributes (CQAs) to meet quality control requirements for transdermal formulation.
The analysis and testing of transdermal formulations play an important role in the development, production, quality control, and clinical application of preparations. It can help developers determine the chemical structure and properties of drugs and provide a basis for drug design and optimization. It can also assist production personnel in controlling the quality of drugs and ensuring the consistency and stability of drugs. Safe, effective, and quality-controllable transdermal formulations can only be prepared through the thorough evaluation of key quality attributes, such as routine characterization and stability, alongside proper risk management and scientific product development.
Services | Available Test Items |
Conventional Characterization for Transdermal Formulation | To ensure the safety, effectiveness, stability, and controllable quality of drugs, we provide conventional characterization analysis for your transdermal formulation, including appearance analysis, weight testing, thickness testing, drug content and expand content assays, and drug content uniformity testing, etc., to ensure your formulation is delivered promptly and efficiently. |
Nanoproperty Characterization for Transdermal Formulation | Transdermal delivery of nanoparticles has a strong impact on improved penetration and permeation, patient compliance, and prolonged effects. We provide nanoproperty characterization analysis for your transdermal formulation, including nanoproperty characterization testing for your formulation, including nanostructures visualization analysis, nano transdermal formulation size distribution testing, nano transdermal formulation zeta potential testing, etc. |
Quality Control and Release Testing | Due to the particularity of the transdermal drug delivery route, during the development process of transdermal formulation, key quality attributes of the product must also be focused on. We offer a full suite of analytical techniques to evaluate your transdermal formulation, including transdermal formulation API and excipient characterization, transdermal formulation analytical method development and validation, and transdermal formulation analytical method transfer. |
Our analytical team specializes in providing regulatory-compliant analytical methods for transdermal formulation analysis and testing. Our expertise includes:
CD Formulation can test transdermal formulation according to customer requirements, with fast testing and favorable prices. Thank you for choosing CD Formulation's transdermal formulation analysis and testing services. If you have a requirement about our services, please contact us by phone or email, our colleagues will reply to you within three working days.